LGP (ASX) General Company Chat

Originally posted by Joannie: ↑
Health & Biotech Cannabis
Picture: Getty Images
Weed Week: Australian medical cannabis prescriptions are soaring
Health & Biotech
9 hours ago|Derek Rose

SHARE
The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing.
There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year ago, Australia’s Therapeutic Goods Administration disclosed this week.
February’s 8,057 approvals were the previous record. There had been an average of 5,000 prescriptions issued in the previous 12 months.
Source: TGA
Since the medical marijuana access scheme was implemented in 2016 there have now been over 100,000 prescriptions issued to an unknown number of patients. (The TGA says it receives de-identified applications and can’t match them to individual patients.)
These figures don’t even include prescriptions written by “authorised prescribers” who often prescribe a high volume of cannabis and don’t have to seek TGA approval for each individual script.
As of the end of February, there were 215 “authorised prescribers”, up from 179 at the start of the year and just 29 in December 2019.
Under the TGA’s rules patients can access marijuana to treat cancer and non-cancer pain; anorexia and wasting associated with chronic illness; chemotherapy-induced nauseua; and other conditions.
Elsewhere this week, in North America, a legalisation bill advanced in the US state of Connecticut as well as in Mexico.
Meanwhile, of the 36 companies in the ASX cannabis sector, 15 gained ground over the past week and 11 lost it.
The biggest gainer wasEve Investments, up 16.7 per cent to 0.7c on no news.
MGC Pharmaceuticals(ASX:MXC)has been the best performer year-to-date, up 180 per cent to 7c.

EVE EVE Investments 0.7 16.7 -0.2 -40.0 $23,058,851
MXC Mgc Pharmaceuticals 7 12.9 4.5 191.7 $155,003,662
BDA Bod Australia 52.5 11.7 3.5 34.2 $52,382,840
MDC Medlab Clinical 26.5 10.4 2.5 36.8 $82,013,915
EPN Epsilon Healthcare 21.5 7.5 -2 -8.5 $39,995,959
DTZ Dotz Nano 36.5 7.4 12.5 23.7 $139,261,480
AGH Althea Group 51 5.2 7.5 8.5 $131,186,770
IHL Incannex Healthcare 21.5 4.9 6.5 144.2 $227,575,256
WOA Wide Open Agricultur 72.5 4.3 -16.5 -27.6 $65,806,600
ECS ECS Botanics Holding 5.1 4.1 1.2 117.4 $29,507,665
LGP Little Green Pharma 72.5 3.6 16 151.7 $95,932,737
EXL Elixinol Global 18.5 2.8 1 19.4 $58,216,430
CPH Creso Pharma 20.5 2.5 2.5 528.8 $214,893,089
CAN Cann Group 55 1.9 -4 32.5 $152,814,450
ZLD Zelira Therapeutics 6.1 1.7 -3.1 -12.9 $72,609,701
CGB Cann Global 0.8 0.0 0.1 100.0 $41,114,042
CAU Cronos Australia 12 0.0 -1 50.0 $6,807,500
EN1 Engage:Bdr 0.6 0.0 0 9.1 $14,691,429
ESE Esense-Lab 1.8 0.0 0 0.0 $9,180,684
NTI Neurotech Intl 7.6 0.0 3.1 442.9 $47,934,074
RNO Rhinomed 12.5 0.0 -3.5 -26.5 $30,457,096
ROO Roots Sustainable 1.9 0.0 -0.2 -20.8 $10,255,895
SCU Stemcell United 2.2 0.0 0.3 100.0 $18,487,054
SUD Suda Pharmaceuticals 4.6 0.0 0.6 12.5 $16,540,208
YPB YPB Group 0.35 0.0 0.15 -12.5 $14,975,462
EOF Ecofibre 119 -0.8 -71.5 -50.4 $400,456,436
PAL Palla Pharma 48.5 -2.0 -28.5 -30.1 $80,147,016
AC8 Auscann Grp Hlgs 13.5 -3.6 -6 -6.7 $61,676,595
LV1 Live Verdure 25 -3.8 6
$10,607,222
MMJ MMJ Group Hlds 11 -4.3 -1.5 27.8 $25,294,938
APH AP Hemp 41 -4.7 7 141.2 $32,049,307
BOT Botanix Pharma 9.3 -5.1 -3.2 -6.0 $90,502,213
MRG Murray River Grp 24.5 -7.5 -30.5 -57.4 $11,028,786
LSH Lifespot Health 10.5 -8.7 2.8 112.1 $15,667,427
RGI Roto-Gro Intl 4.9 -9.3 -1.4 8.9 $12,571,092
IDT IDT Australia 36.5 -18.0 18 128.1 $100,900,659
Subscribe to ourdaily newsletter
Join our small capFacebook group
Follow us onFacebookorTwitter
READ MORECANNABIS

SHARE

SUBSCRIBE
Get the latest * news delivered free to your inbox.
Name*

Email*

It's free. Unsubscribe whenever you want.
Read ourprivacy policy
Actually another apology, reading it more throughly I think YTD it is 4th from the top. Pretty good anyway. Joannie
Expand
Haha, the comparison between companies is only about stock price change, LGP would be first if it was about sales. The article is on stok hed (keeps getting censored).

No.	Vol.	Price($)
10	901004	10.0¢

No.

Vol.

Price($)

901004

10.0¢

Price($)	Vol.	No.
11.0¢	94990	4

Price($)

Vol.

No.

11.0¢

94990

No.	Vol.	Price($)
10	901004	0.100
1	10000	0.099
1	3723	0.098
2	5855	0.096
5	171498	0.095

No.

Vol.

Price($)

901004

0.100

10000

0.099

3723

0.098

5855

0.096

171498

0.095

Price($)	Vol.	No.
0.110	94990	4
0.115	74223	4
0.120	57043	4
0.125	70099	1
0.130	1297970	7

Price($)

Vol.

No.

0.110

94990

0.115

74223

0.120

57043

0.125

70099

0.130

1297970

(20min delay)
Last 10.0¢		Change 0.000(0.00%)		Mkt cap ! $30.17M

Open	High	Low	Value	Volume
10.0¢	11.0¢	10.0¢	$14.42K	139.1K

Haha, the comparison between companies is only about stock price...

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Haha, the comparison between companies is only about stock price...

SUBSCRIBE

Top Stories

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News